Integra Lifesciences Holdings (IART) EPS (Basic) Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 114.97% |
| 10 | Integra Lifesciences Holdings | 1.51 Bn | 1.24 Bn | 216.98 Mn | 81.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.86% |
| Dec 31, 2025 | -108.81% |
| Sep 30, 2025 | 49.67% |
| Jun 30, 2025 | -3,839.52% |
| Mar 31, 2025 | -683.72% |
| Dec 31, 2024 | 1.91% |
| Sep 30, 2024 | -157.18% |
| Jun 30, 2024 | -410.04% |
| Mar 31, 2024 | -114.26% |
| Dec 31, 2023 | -61.18% |
| Sep 30, 2023 | -59.30% |
| Jun 30, 2023 | -90.40% |
| Mar 31, 2023 | -24.78% |
| Dec 31, 2022 | 19.05% |
| Sep 30, 2022 | 17.85% |
| Jun 30, 2022 | 30.05% |
| Mar 31, 2022 | -26.77% |
| Dec 31, 2021 | -51.09% |
| Sep 30, 2021 | 33.01% |
| Jun 30, 2021 | 9,605.66% |